Basilar arteries with experimental vasospasm were studies histochemically using a catecholamine fluorescence technique in 15 cats. Fluorescence microscopy of normal vessels revealed abundant catecholamine fluorescence in the adventitia and in close contact with the media, but none within the media. Experimental subarachnoid hemorrhage resulted in depletion of catecholamine fluorescence in the adventitia and in its appearance in the media. In vessels with vasospasm which lasted for 2 or 5 h and responded to vasodilators, fluorescence was scarce in the adventitia, but abundant in the media. In vessels with vasospasm unresponsive to spasmolytic agents, fluorescence was observed neither in the adventitia nor in the media. The results suggest th...
INTRODUCTION: Intracisternal blood injection is the most common applied experimental subarachnoid bl...
Objective We developed an in vitro model for vasospasm post subarachnoid hemorrhage that was suitabl...
The effects of a PGI2 analogue (OP-41483), a thromboxane A2 synthetase inhibitor (OKY-046) and a Ca ...
Basilar arteries with experimental vasospasm were studies histochemically using a catecholamine fluo...
Ultrastructural and histochemical changes of experimental vasospasm were studied in 46 cats. Prolong...
This study demonstrates that an adrenergic mechanism plays an important role in producing the delaye...
Delayed cerebral vasospams is caused by excessive accumulation of dopamine-beta-hydroxylase (DBH) an...
Precise in vivo evaluation of cerebral vasospasm caused by subarachnoid hemorrhage has remained a cr...
Studies of cerebral vasospasm were performed using two different experimental models. The duration a...
<div><p>Precise <em>in vivo</em> evaluation of cerebral vasospasm caused by subarachnoid hemorrhage ...
Cerebral vasospasm is a common cause of ischemia and death in patients suffering from cerebral hemor...
Intracranial aneurysmal rupture is the common cause of spontaneous subarachnoid haemorrhage (SAH). T...
Aims: The purpose of the research presented in this thesis is to elucidate the mechanis...
Objective To establish and compare the early cerebral vasospasm (CVS) caused by 2 subarachnoid hemor...
The effects of a thromboxane A(2) synthetase inhibitor (OKY-046: sodium (E)-3-[4-(1-imidazolylmethyl...
INTRODUCTION: Intracisternal blood injection is the most common applied experimental subarachnoid bl...
Objective We developed an in vitro model for vasospasm post subarachnoid hemorrhage that was suitabl...
The effects of a PGI2 analogue (OP-41483), a thromboxane A2 synthetase inhibitor (OKY-046) and a Ca ...
Basilar arteries with experimental vasospasm were studies histochemically using a catecholamine fluo...
Ultrastructural and histochemical changes of experimental vasospasm were studied in 46 cats. Prolong...
This study demonstrates that an adrenergic mechanism plays an important role in producing the delaye...
Delayed cerebral vasospams is caused by excessive accumulation of dopamine-beta-hydroxylase (DBH) an...
Precise in vivo evaluation of cerebral vasospasm caused by subarachnoid hemorrhage has remained a cr...
Studies of cerebral vasospasm were performed using two different experimental models. The duration a...
<div><p>Precise <em>in vivo</em> evaluation of cerebral vasospasm caused by subarachnoid hemorrhage ...
Cerebral vasospasm is a common cause of ischemia and death in patients suffering from cerebral hemor...
Intracranial aneurysmal rupture is the common cause of spontaneous subarachnoid haemorrhage (SAH). T...
Aims: The purpose of the research presented in this thesis is to elucidate the mechanis...
Objective To establish and compare the early cerebral vasospasm (CVS) caused by 2 subarachnoid hemor...
The effects of a thromboxane A(2) synthetase inhibitor (OKY-046: sodium (E)-3-[4-(1-imidazolylmethyl...
INTRODUCTION: Intracisternal blood injection is the most common applied experimental subarachnoid bl...
Objective We developed an in vitro model for vasospasm post subarachnoid hemorrhage that was suitabl...
The effects of a PGI2 analogue (OP-41483), a thromboxane A2 synthetase inhibitor (OKY-046) and a Ca ...